TCHP and liver cancer: Liver cancer cells have mutations in the gene encoding the tumor suppressor protein p53 driven by NRAS become addicted to MYC stabilization, which enables the tumor cells to overcome a latent G2/M cell cycle arrest, thus promoting the proliferation of HCC33.